Search Results - "Rüger, Petra"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity by Thomann, Marco, Schlothauer, Tilman, Dashivets, Tetyana, Malik, Sebastian, Avenal, Cecile, Bulau, Patrick, Rüger, Petra, Reusch, Dietmar

    Published in PloS one (12-08-2015)
    “…The importance and effect of Fc glycosylation of monoclonal antibodies with regard to biological activity is widely discussed and has been investigated in…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function by Popp, Oliver, Moser, Samuel, Zielonka, Jörg, Rüger, Petra, Hansen, Silke, Plöttner, Oliver

    Published in mAbs (17-02-2018)
    “…Novel biotherapeutic glycoproteins, like recombinant monoclonal antibodies (mAbs) are widely used for the treatment of numerous diseases. The N-glycans…”
    Get full text
    Journal Article
  5. 5

    Mutants of Protein Kinase A that Mimic the ATP-binding Site of Protein Kinase B (AKT) by Gaßel, Michael, Breitenlechner, Christine B., Rüger, Petra, Jucknischke, Ute, Schneider, Thorsten, Huber, Robert, Bossemeyer, Dirk, Engh, Richard A.

    Published in Journal of molecular biology (20-06-2003)
    “…The mutation of well behaved enzymes in order to simulate less manageable cognates is the obvious approach to study specific features of the recalcitrant…”
    Get full text
    Journal Article
  6. 6

    Biosensor based on an enzyme modified electrode for highly-sensitive measurement of polyphenols by Eremenko, Arkadi, Makower, Alexander, Jin, Wen, Rüger, Petra, Scheller, Frieder

    Published in Biosensors & bioelectronics (1995)
    “…The use of glucose dehydrogenase from Acinetobacter calcoaceticus for highly sensitive measurement of polyphenols, based on bioelectrocatalytic analyte…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function by Popp, Oliver, Moser, Samuel, Zielonka, Jörg, Rüger, Petra, Hansen, Silke, Plöttner, Oliver

    Published in mAbs (17-02-2018)
    “…Novel biotherapeutic glycoproteins, like recombinant monoclonal antibodies (mAbs) are widely used for the treatment of numerous diseases. The N-glycans…”
    Get full text
    Report
  9. 9